Cerapedics Overview

  • Founded
  • 2000
Founded
  • Status
  • Private
  • Employees
  • 35
Employees
  • Latest Deal Type
  • Debt Refin.
  • Latest Deal Amount
  • $45M
Latest Deal Amount
  • Investors
  • 6

Cerapedics General Information

Description

Developer of ortho-biological technology intended to provide a proprietary synthetic small peptide technology platform. The company's ortho-biological technology is focused on developing and commercializing novel osteobiologic products that incorporate a small peptide as an attachment factor to stimulate the natural bone healing process, enabling physicians to support safer and more predictable bone formation compared to commercially available bone growth factors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Primary Office
  • 11025 Dover Street
  • Suite 1600
  • Westminster, CO 80021
  • United States
+1 (303) 000-0000

Cerapedics Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cerapedics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Debt Refinancing 22-Mar-2019 $45M 00000 Completed Generating Revenue
10. Later Stage VC (Series E) 06-Jul-2018 0000 00000 00000 Completed Generating Revenue
9. Debt - General 19-Apr-2017 0000 00000 Completed Generating Revenue
8. Later Stage VC (Series D) 23-Sep-2016 0000 000.00 0000 Completed Generating Revenue
7. Debt - General 22-Apr-2016 00.000 000.00 Completed Generating Revenue
6. Later Stage VC (Series C) 23-Feb-2015 000 000.00 000.00 Completed Generating Revenue
5. Debt - General 14-Apr-2014 000 000.00 Completed Generating Revenue
4. Later Stage VC (Series C) 12-Dec-2012 0000 000.00 000.00 Completed Generating Revenue
3. Grant 31-Dec-2009 $240K $29.5M Completed Generating Revenue
2. Later Stage VC (Series B) 30-Mar-2009 $15M $29.5M 000.00 Completed Generating Revenue
To view Cerapedics’s complete valuation and funding history, request access »

Cerapedics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series D 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series C 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series B 13,256,314 $0.010000 7% $1.37 $1.37 1x $1.37 13.87%
Series A 14,457,000 $0.010000 7% $1 $1 1x $1 15.12%
To view Cerapedics’s complete cap table history, request access »

Cerapedics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of ortho-biological technology intended to provide a proprietary synthetic small peptide technology platform.
Other Healthcare Technology Systems
Westminster, CO
35 As of 2018
00000
000000000 00 00000

000000 0

nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit e
0000000000000
Vancouver, Canada
00 As of 0000
000.00
00000000000 000.00

00000000

ute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Exc
0000000000000
Schlieren, Switzerland
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cerapedics Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aspect Biosystems Venture Capital-Backed Vancouver, Canada 00 000.00 00000000000 000.00
00000000 Formerly VC-backed Schlieren, Switzerland 00 000.00 0000000000 0 000.00
00000000 Formerly VC-backed Solana Beach, CA 0 0000 000000&0
0000 000000000 Corporation Burlington, MA 0 000.00 000000000 000.00
000000 00000000000 Venture Capital-Backed Plymouth, MI 0 00.000 000000 - 000 00.000
To view Cerapedics’s complete competitors history, request access »

Cerapedics Executive Team (20)

Name Title Board Seat Contact Info
Glen Kashuba Chief Executive Officer & Board Member
Jeffery Marx Ph.D President & Chief Operating Officer
Drew Trivisonno Chief Financial Officer
John Tattory Chief Financial Officer
Andy Woods Director, Commercial Development
You’re viewing 5 of 20 executive team members. Get the full list »

Cerapedics Board Members (15)

Name Representing Role Since
Andrew Tofe Ph.D Cerapedics Founder & Board Member 000 0000
Antony Koblish Self Chairman 000 0000
Chau Khuong OrbiMed Board Member 000 0000
Douglas Kohrs Self Board Member 000 0000
Glen Kashuba Cerapedics Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

Cerapedics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cerapedics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
KCK Group Family Office Minority 000 0000 000000 0
Revelation Partners Venture Capital Minority 000 0000 000000 0
Crown Venture Fund Venture Capital Minority 000 0000 000000 0
MedImmune Ventures Corporate Venture Capital Minority 000 0000 000000 0
NGN Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »